Benjamin Mordmüller
Benjamin Mordmüller
Correu electrònic verificat a uni-tuebingen.de
TítolCitada perAny
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
7462011
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
The Lancet 386 (9988), 31-45, 2015
539*2015
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
3112016
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria.
JFJ Kun, B Mordmuller
The Lancet 351 (9098), 265-265, 1998
2101998
Nitric Oxide Synthase 2Lambaréné (G‐954C), Increased Nitric Oxide Production, and Protection against Malaria
JF Kun, B Mordmüller, DJ Perkins, J May, O Mercereau‐Puijalon, ...
The Journal of infectious diseases 184 (3), 330-336, 2001
1982001
Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-γ-mediated effect
OA Skorokhod, M Alessio, B Mordmüller, P Arese, E Schwarzer
The Journal of Immunology 173 (6), 4066-4074, 2004
1792004
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ...
Nature 542 (7642), 445-449, 2017
1722017
Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism
B Mordmüller, D Krappmann, M Esen, E Wegener, C Scheidereit
EMBO reports 4 (1), 82-87, 2003
1612003
The IκB kinase complex and NF-κB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1
D Krappmann, E Wegener, Y Sunami, M Esen, A Thiel, B Mordmuller, ...
Molecular and cellular biology 24 (14), 6488-6500, 2004
1522004
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS The, SCT Partnership
PLoS medicine 11 (7), 2014
1452014
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies
MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ...
Journal of Experimental Medicine 210 (2), 389-399, 2013
1412013
Selection of a trioxaquine as an antimalarial drug candidate
F Coslédan, L Fraisse, A Pellet, F Guillou, B Mordmüller, PG Kremsner, ...
Proceedings of the National Academy of Sciences 105 (45), 17579-17584, 2008
1362008
Malaria pigment in leucocytes
WG Metzger, BG Mordmüller, PG Kremsner
Transactions of the Royal Society of Tropical Medicine and Hygiene 89 (6 …, 1995
1181995
Notch ligands Delta‐like1, Delta‐like4 and Jagged1 differentially regulate activation of peripheral T helper cells
S Rutz, B Mordmüller, S Sakano, A Scheffold
European journal of immunology 35 (8), 2443-2451, 2005
1132005
Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate
M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ...
Vaccine 27 (49), 6862-6868, 2009
1122009
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
TL Richie, PF Billingsley, BKL Sim, ER James, S Chakravarty, JE Epstein, ...
Vaccine 33 (52), 7452-7461, 2015
1032015
Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance.
BG Mordmüller, WG Metzger, P Juillard, BM Brinkman, CL Verweij, ...
European cytokine network 8 (1), 29-35, 1997
1021997
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults
JL Grogan, PG Kremsner, GJ van Dam, W Metzger, B Mordmüller, ...
Journal of Infectious Diseases 173 (5), 1242-1247, 1996
1001996
Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon
A Kreidenweiss, PG Kremsner, B Mordmüller
Malaria journal 7 (1), 187, 2008
992008
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
M Ramharter, F Kurth, AC Schreier, J Nemeth, I von Glasenapp, S Bélard, ...
The Journal of infectious diseases 198 (6), 911-919, 2008
872008
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20